Zimmer Biomet (ZBH) PT Raised to $153 at Truist Securities
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $87.09 -1%
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $137.00) while maintaining a Hold rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Macy's (M) PT Raised to $25 at TD Cowen
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
